I learned about a trial with Medtronic's iPro, a clinical version of a CGM, that's inserted in the endocrinologist's office, worn for three days, and then returned to the doctor. The data is then uploaded and analyzed to determine sufficient need for a CGM, warranting coverage by insurance.
Category: CGMs, Meters & Pumps
Ascensia Diabetes Care has received CE Mark for the new CONTOUR NEXT ONE and CONTOUR PLUS ONE blood glucose monitoring systems, which will allow…
I got my first CGM three and a half weeks before I ran the Vienna marathon. I used it on my final long training run (23 miles), and on my short runs leading…
Medtronic Inc. has announced the publication of new data in Diabetes, Obesity and Metabolism from the continuation phase of the OpT2mise study,…
LifeScan has introduced the new OneTouch Verio Flex blood glucose monitoring system, with ColorSure technology – a simple, accurate and easy-to-use…
Type Zero Technologies' chief mathematician, Dr. Boris Kovatchev, reached out to Riding on Insulin to gauge interest in being part of a groundbreaking artificial pancreas trial.
Abbott Diabetes Care announced that it has obtained CE Mark for the FreeStyle Libre flash glucose monitoring system indicated for children and teens with diabetes aged 4-17 years old.
Bigfoot’s goal is to make pump-sensor therapy simpler than the pump companies before them have. They envision themselves as a service provider rather than a hardware or device company. Their service will be to “do a better job delivering insulin,” automating your between-meal insulin therapy, the communication between your pump and your Dexcom CGM, even so far as serving as a single point of contact for all of your supply and prescription inventory management, sending you supplies when you need them, “connecting everything, making it intuitive,” says Brewer.
The U.S. FDA has approved Animas Vibe Insulin Pump and Continuous Glucose Monitoring (CGM) System for management of diabetes in children and adolescents,…
Another insulin coming to us in 2016 is Lilly’s new basal insulin, Basaglar – a form of insulin glargine (which you may recognize if you’re familiar with Lantus). FDA approved it just this week after a patent dispute was finally resolved with Sanofi.